[1. Ohman EM, Bhatt DL, Steg PG, Goto S, Hirsch AT, Liau CS, et al. The Reduction of Atherothrombosis for Continued Health (REACH) Registry: an international, prospective, observational investigation in subjects at risk for atherothrombotic events-study design. Am Heart J. 2006 Apr;151(4):786-96. DOI: 10.1016/j.ahj.2005.11.00410.1016/j.ahj.2005.11.00416569533]Search in Google Scholar
[2. Markus HS. Stroke genetics. Hum Mol Genet. 2011 Oct 15;20(R2):R124-31. DOI: 10.1093/hmg/ddr34510.1093/hmg/ddr34521831884]Search in Google Scholar
[3. Cinteza M, Pana B, Cochino M, Florescu M, Margulescu M, Florian A, et al. Prevalence and control of cardiovascular risk factors in Romania cardio-zone national study. Mædica. 2007 May; 2(4):277-88.]Search in Google Scholar
[4. Della-Morte D, Guadagni F, Palmirotta R, Testa G, Caso V, Paciaroni M, et al. Genetics of ischemic stroke, stroke-related risk factors, stroke precursors and treatments. Pharmacogenomics. 2012 Apr;13(5):595-613. DOI: 10.2217/pgs.12.1410.2217/pgs.12.1422462751]Search in Google Scholar
[5. Goracy J, Goracy I, Kaczmanczyk M, Brykcz M, Widwcka-Ostreska K, Taryna O, et al. Common genetic polymorphisms and environmental risk factors in Polish patients with angiographically documented coronary artery disease. Pol.J.Environ. 2011 May;20(6):1491-99.]Search in Google Scholar
[6. Sheweita SA, Baghdadi H, Allam AR. Role of genetic changes in the progression of cardiovascular diseases. Int J Biomed Sci. 2011 Dec;7(4):238-48.]Search in Google Scholar
[7. Imran Imran, Rusdi Lamsudin, Ponpon Idjiradinata, Tri Hanggono Achmad, Amelani Maskoen, Samekto Wibowo, et al. Association of β-fibrinogen promoter gene polymorphism (-148C/T), hyperfibrinogenemia and ischemic stroke in young adult patients. Egypt J Med Hum Genet. 2015 Jan;16(1):11-17. DOI: 10.1016/j.ejmhg.2014.09.00410.1016/j.ejmhg.2014.09.004]Search in Google Scholar
[8. Emerging Risk Factors Collaboration, Kaptoge S, Di Angelantonio E, Pennells L, Wood AM, White IR, Gao P, et al. C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med. 2012 Oct 4;367(14):1310-20. DOI: 10.1056/NEJMoa110747710.1056/NEJMoa1107477371410123034020]Search in Google Scholar
[9. Bentley P, Peck G, Smeeth L, Whittaker J, Sharma P. Causal relationship of susceptibility genes to ischemic stroke: comparison to ischemic heart disease and biochemical determinants. PLoS One. 2010 Feb 9;5(2):9136. DOI: 10.1371/journal.pone.000913610.1371/journal.pone.0009136281772620161734]Search in Google Scholar
[10. Cao YJ, Zhang X, Wang WH, Zhai WQ, Qian JF, Wang JS. Oral fibrinogen-depleting agent lumbrokinase for secondary ischemic stroke prevention: results from a multicenter, randomized, parallel-group and controlled clinical trial. Chin Med J (Engl). 2013 Nov;126(21):4060-5.]Search in Google Scholar
[11. Kumar A, Sagar R, Kumar P, Sahu JK, Grover A, Srivastava AK, et al. Identification of genetic contribution to ischemic stroke by screening of single nucleotide polymorphisms in stroke patients by using a case control study design. BMC Neurol. 2013 Oct 3;13:136. DOI: 10.1186/1471-2377-13-13610.1186/1471-2377-13-136385155824090469]Search in Google Scholar
[12. Martiskainen M, Pohjasvaara T, Mikkelsson J, Mäntylä R, Kunnas T, Laippala P, et al. Fibrinogen gene promoter -455 A allele as a risk factor for lacunar stroke. Stroke. 2003 Apr;34(4):886-91. DOI: 10.1161/01.STR.0000060029.23872.5510.1161/01.STR.0000060029.23872.5512637691]Search in Google Scholar
[13. Wu G, Cai H, Cai H, Chen Z, Tan L, Qi H, et al. Effect of the -148C/T, 448G/A, and -854G/A Polymorphisms of the β-Fibrinogen Gene on the Risk of Ischemic Stroke in Chinese Population. J Stroke Cerebrovasc Dis. 2015 Jul;24(7):1577-90. DOI: 10.1016/j.jstrokecerebrovasdis.2015.03.02910.1016/j.jstrokecerebrovasdis.2015.03.02925890854]Search in Google Scholar
[14. Pongrácz E, Andrikovics H, Csornai M, Bernát IS, Nagy Z. Contribution of the -455G/A polymorphism at beta-fibrinogen gene and of the Leiden mutation to hemorheological parameters in ischemic stroke patients. Clin Hemorheol Microcirc. 2006;35(1-2):75-82.]Search in Google Scholar
[15. Floyd CN, Ferro A. The platelet fibrinogen receptor: from megakaryocyte to the mortuary. JRSM Cardiovasc Dis. 2012 May 31;1(2). pii: cvd.2012.012007.10.1258/cvd.2012.012007373832424175064]Search in Google Scholar
[16. Galasso G, Santulli G, Piscione F, De Rosa R, Trimarco V, Piccolo R, et al. The GPIIIA PlA2 polymorphism is associated with an increased risk of cardiovascular adverse events. BMC Cardiovasc Disord. 2010 Sep 16;10:41. DOI: 10.1186/1471-2261-10-4110.1186/1471-2261-10-41295487420846430]Search in Google Scholar
[17. Floyd CN, Ellis BH, Ferro A. The PlA1/A2 polymorphism of glycoprotein IIIa as a risk factor for stroke: a systematic review and meta-analysis. PLoS One. 2014 Jul 2;9(7):e100239. DOI: 10.1371/journal.pone.0100239 DOI: 10.1371/journal.pone.010151810.1371/journal.pone.0100239407924524988537]Search in Google Scholar
[18. Lievens D, von Hundelshausen P. Platelets in atherosclerosis. Thromb Haemost. 2011 Nov;106(5):827-38. DOI: 10.1160/TH11-08-059210.1160/TH11-08-059222012554]Search in Google Scholar
[19. Nurden AT. Platelets, inflammation and tissue regeneration. Thromb Haemost. 2011May;105 Suppl 1:S13-33. DOI: 10.1160/THS10-11-072010.1160/THS10-11-072021479340]Search in Google Scholar
[20. Promega Corporation, Instructions for Use of Product(s) A1120, A1125, A1620, Wiyard Genomic DNA Purification Kit Technical Manual, Ma, USA, revised 12/2010. www.promega.com.]Search in Google Scholar
[21. Available from: http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=5918. [cited 2015.10.30].]Search in Google Scholar
[22. Available from: http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=1800790. [cited 2015.10.30].]Search in Google Scholar
[23. Undas A. Fibrin clot properties and their modulation in thrombotic disorders. Thromb Haemost. 2014 Jul 3;112(1):32-42. DOI: 10.1160/TH14-01-003210.1160/TH14-01-003224671700]Search in Google Scholar
[24. Broos K, Feys HB, De Meyer SF, Vanhoorelbeke K, Deckmyn H. Platelets at work in primary hemostasis. Blood Rev. 2011 Jul;25(4):155-67. DOI: 10.1016/j.blre.2011.03.00210.1016/j.blre.2011.03.00221496978]Search in Google Scholar
[25. Available from: http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=1800790. [cited 2015.07.15].]Search in Google Scholar
[26. Available from: http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=5918. [cited 2015.08.05].]Search in Google Scholar
[27. Pongracz E, Scweitzer K, Furesz J, Fent J, Tordai A, Nagy Z. The effects of platelet receptor GPIIb/IIIa polymorphism (Leu Pro33) on the receptor expression and platelet aggregation in patients with ishaemic stroke. Turk J Hematol. 2007 Sep;24(4):155-163.]Search in Google Scholar
[28. Guo J, Liu A, Su D. Genetics of stroke. Acta Pharm Sinic 2010 Aug; 31:1055–1064. DOI: 10.1038/aps.2010.14110.1038/aps.2010.141400231620729874]Search in Google Scholar
[29. Siengerink B, Rosendaal F.R, Algra A. Genetic variation in fibrinogen; its relantionship to fibrinogen levels and the risk of myocardial infarction and ischemic stroke. J Thromb Haemost. 2009 Mar;7(3):385-90. DOI: 10.1111/j.1538-7836.2008.03266.x10.1111/j.1538-7836.2008.03266.x19143925]Search in Google Scholar
[30. Lee SH, Kim MK, Park MS, Choi SM, Kim JT, Kim BC, et al. Beta-fibrinogen -455 G/A polymorphism in Korean ischemic stroke patients. J Clin Neurol. 2008 Mar;4(1):17-22. DOI: 10.3988/jcn.2008.4.1.1710.3988/jcn.2008.4.1.17268688319513319]Search in Google Scholar
[31. Golenia A, Chrzanowska-Wasko J, Jagiella J, Wunk M, Ferens A, Klimkowicz-Mrowiec A, et al. The β-fibrinogen -455G/A gene polymorphism and the risk of ischaemic stroke in a Polish population. Neurol Neurochir Pol. 2013 Mar-Apr;47(2):152-6. DOI: 10.5114/ninp.2013.3446210.5114/ninp.2013.3446223650004]Search in Google Scholar
[32. Kessler C, Spitzer C, Stauske D, Mende S, Stadlmuller J, Walther R, et al. The apolipoprotein E and beta-fibrinogen G/A-455 gene polymorphisms are associated with ischemic stroke involving large vessel disease. Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):2880-4. DOI: 10.1161/01.ATV.17.11.288010.1161/01.ATV.17.11.2880]Search in Google Scholar
[33. Liu Y, Pan J, Wang S, Li X, Huang Y. Beta-fibrinogen gene -455A/G polymorphism and plasma fibrinogen level in Chinese stroke patients. Chin Med J (Engl). 2002 Feb;115(2):214-6.]Search in Google Scholar
[34. Ridker PM, Hennekens CH, Schmitz C, Stampfer MJ, Lindpaintner K. Lancet. PIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis. Lancet. 1997 Feb 8;349(9049):385-8. DOI: 10.1016/S0140-6736(97)80010-410.1016/S0140-6736(97)80010-4]Search in Google Scholar
[35. Li Q, Chen BL, Ozdemir V, Ji W, Mao YM, Wang LC, et al. Frequency of genetic polymorphisms of COX1, GPIIIa and P2Y1 in a Chinese population and association with attenuated response to aspirin. Pharmacogenomics. 2007 Jun;8(6):577-86. DOI: 10.2217/14622416.8.6.57710.2217/14622416.8.6.57717559347]Search in Google Scholar
[36. Floyd CN, Mustafa A, Ferro A. The PlA1/A2 polymorphism of glycoprotein IIIa as a risk factor for myocardial infarction: a meta-analysis. PLoS One. 2014 Jul 2;9(7):e101518. DOI: 10.1371/journal.pone.010151810.1371/journal.pone.0101518407971724988220]Search in Google Scholar
[37. Carter AM, Catto AJ, Bamford JM, Grant PJ. Platelet GP IIIa PlA and GP Ib variable number tandem repeat polymorphisms and markers of platelet activation in acute stroke. Arterioscler Thromb Vasc Biol. 1998 Jul;18(7):1124-31. DOI: 10.1161/01.ATV.18.7.112410.1161/01.ATV.18.7.11249672073]Search in Google Scholar
[38. Lanni F1, Santulli G, Izzo R, Rubattu S, Zanda B, Volpe M, et al. The Pl(A1/A2) polymorphism of glycoprotein IIIa and cerebrovascular events in hypertension: increased risk of ischemic stroke in high-risk patients. J Hypertens. 2007 Mar;25(3):551-6. DOI: 10.1097/HJH.0b013e328013cd6710.1097/HJH.0b013e328013cd6717278970]Search in Google Scholar
[39. Oksala NK1, Heikkinen M, Mikkelsson J, Pohjasvaara T, Kaste M, Erkinjuntti T, et al. Smoking and the platelet fibrinogen receptor glycoprotein IIb/IIIA PlA1/A2 polymorphism interact in the risk of lacunar stroke and midterm survival. Stroke. 2007 Jan;38(1):50-5. DOI: 10.1161/01.STR.0000251719.59141.3610.1161/01.STR.0000251719.59141.3617138951]Search in Google Scholar